Eight Hyped Compounds Failed to Extend Lifespan in a Major Mouse Study

Starke Evidenz·Animal Study·GeroScience·März 2026

The NIA's Interventions Testing Program tested eight compounds across three lab sites in genetically diverse mice. None extended lifespan. That includes astaxanthin, alpha-ketoglutarate, pioglitazone, atorvastatin-telmisartan, and others with prior promising results. Some compounds previously shown to work at different doses or start ages didn't replicate under new conditions. Two drugs actually shortened lifespan in female mice.

Key Insight

This study suggests that dose and timing matter enormously, and early lifespan results in mice often don't hold up.

Originalstudie

GeroScience··UM-HET3 mice across three sites (exact N not specified)

Verwandte Studien

We May Not Be Aging Slower. We're Just Starting Later.

A big question in longevity research is whether rising life expectancy means we're actually aging more slowly. This analysis of mortality data from 12 countries suggests the answer is no. After accounting for historical shocks like wars and pandemics, the rate at which aging accelerates after 80 hasn't changed. The gains in lifespan appear to come from pushing back when serious aging begins, not from slowing the process itself.

Proceedings of the National Academy of Sciences of the United States of America·Moderat·8. Apr. 2026

Metformin's Anti-Aging Case: Strong Clues but Still No Proof

This review pulls together lab, population, and clinical trial evidence on metformin as a potential aging-slowing drug. At normal doses, metformin seems to flip several key aging switches: boosting cellular cleanup, calming inflammation, and improving energy production. Large population studies link metformin use to lower rates of age-related diseases, even in people without diabetes. However, the review honestly notes that metformin may actually worsen aging in older animals, so the picture is still mixed.

Molecular and cellular endocrinology·Moderat·3. Apr. 2026

Centenarians Show a Distinct Metabolic Profile Tied to Bile Acids and NAD+

People who live past 100 have a unique metabolic fingerprint. In a study of 213 participants from the New England Centenarian Study, extremely long-lived individuals had higher levels of certain bile acids and lower levels of bilirubin compared to younger controls. Higher bile acid and steroid levels were linked to lower mortality risk. The researchers also built a "metabolomic clock" that estimates biological age, and deviations from it predicted death risk.

GeroScience·Moderat·26. März 2026

Haftungsausschluss: Forschungszusammenfassungen dienen nur zu Informationszwecken und stellen keine medizinische Beratung dar. Konsultieren Sie immer einen qualifizierten Arzt, bevor Sie Änderungen an Ihrer Gesundheitsroutine vornehmen.